JNJ-41443532 Sex, Race, and Age Pharmacokinetic (PK) Study

NCT01105780 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Placebo
DRUG: JNJ-41443532

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.